The Europe intragastric balloon market is anticipated to register a CAGR of 11.83%, during the forecast period of 2019 to 2028. An unhealthy lifestyle, a rise in government initiatives, and a growing obese population base are expected to facilitate market growth.

To know more about this report, request a free sample copy

The countries considered for analyzing the Europe intragastric balloon market growth are the United Kingdom, Germany, France, Belgium, Poland, Russia, Italy, and the rest of Europe. Obesity has recorded to be consistently increasing and regarded as a severe health crisis in France. According to statistics presented by OECD, approximately one in ten people are diagnosed with obesity, and around 40% are overweight, in addition to being obese. Thus, such factors are expected to hike the intragastric balloon market across the forecast period. The highest proportion of obese European population is found in Germany. Moreover, over 60% of Germans are either obese or overweight, and more than one million children in Germany are classified as obese. The rate of obesity in the country can be attributed to factors like increased intake of food high in fats and Mediterranean diet, consisting primarily of fiber, consumption of beer, and lack of physical activity. The Federal Ministry of Health, as well as the Federal Ministry of Food, Agriculture and Consumer Protection in the nation, strive to promote healthy living by strongly emphasizing on reducing obesity and obese population. Moreover, the constant upsurge of obesity among youth has led to conditions like high blood pressure among children and young adults. According to experts, almost 5% of children living in Germany suffer from high blood pressure disorders, thereby fuelling the intragastric balloon market growth in the region. However, stomach ulcer is a risk factor associated with an intragastric balloon placement and hinders the market growth in the region.

Allergan Inc, headquartered in Dublin, Ireland, is an amalgamated global specialty pharmaceutical enterprise. The company concentrates on manufacturing, promoting, and distributing brand name pharmaceutical products, medical aesthetics, over the counter (OTC) clinical products and biosimilar. Allergan also has an assortment of products specially made for eye care, urology, central nervous system, dermatology, women’s health, and gastroenterology, among several other therapeutic categories.

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.